Michelle T. Long MD, MSc
Associate Professor, Preventive Medicine & Epidemiology
Associate Professor, Gastroenterology
85 E. Concord St | (617) 638-8392michelle.long@bmc.org
mtlong@bu.edu
Sections
Preventive Medicine & Epidemiology
Gastroenterology
Centers
Framingham Heart Study
Boston Nutrition Obesity Research Center
Evans Center for Interdisciplinary Biomedical Research
Biography
Michelle T. Long, MD, MSc is a physician-scientist with an expertise in Nonalcoholic fatty liver disease (NAFLD), and an Associate Professor of Medicine at Boston University. She completed her clinical training at Massachusetts General Hospital and Boston Medical Center. Dr. Long is the Director of the NAFLD Research Center and the Director of Clinical Research for the Section of Gastroenterology and Hepatology. Her clinical and research interests center on the relationship between NAFLD and cardiovascular disease. Dr. Long is primarily interested in patient-oriented research investigating fibrosis and inflammation in patients with NAFLD and in imaging and risk stratification strategies for hepatic fibrosis. Dr. Long has projects at Boston Medical Center and at the Framingham Heart Study where she is the PI of a study evaluating the prevalence and risk factors for liver fat (steatosis) and fibrosis. In Framingham, she is investigating the clinical and genetic correlates of hepatic steatosis and fibrosis as measured by transient elastography. Dr. Long receives research funding from the NIH (NIDDK), Doris Duke Charitable Foundation, Gilead Sciences, Echosens Corporation, and Boston University. She has expertise in epidemiology, visceral fat, liver imaging including computed tomography, ultrasound, and transient elastography. Dr. Long is also a clinical hepatologist and endoscopist.
Dr. Long is additionally interested in novel therapeutics for NAFLD and Non-alcoholic steatohepatitis (NASH) and runs the clinical trials program for the NAFLD Research Center.
Her other research interests include alcohol-related liver disease, hepatitis C, outcomes in end-stage liver disease/cirrhosis.
Education
Medicine-Internal, MD, Tufts University School of Medicine
Epidemiology, MSc, Boston University School of Public Health
Neuroscience/Neurology, BA, Middlebury College
Publications
El-Sabawi B, Tanriverdi K, Gajjar P, Nayor M, Landman JM, Below JE, Haff M, Long M, Ezpeleta M, Freedman JE, Varady K, Shah R, Perry AS. Circulating Proteomics Identifies a Dynamic Profile of Hepatic Steatosis During Metabolic Intervention. J Am Heart Assoc. 2025 May 15; e037100. PMID: 40371575.
Published on 4/25/2025Mohanty A, Austad K, Bosch NA, Long MT, Nolen-Doerr E, Walkey AJ, Drainoni ML, Rizo I, Fantasia KL. Assessing Clinician Engagement with a Passive Clinical Decision Support System for Liver Fibrosis Risk Stratification in a Weight Management Clinic. Endocr Pract. 2025 Apr 25. PMID: 40288606.
Published on 4/21/2025Newsome P, Sanyal A, Kliers I, Østergaard L, Long M, Kjær M, Cali AMG, Bugianesi E, Rinella M, Roden M, Ratziu V. Erratum: Late breaking abstracts. Hepatology. 2025 Apr 21. PMID: 40258120.
Published on 2/11/2025Fuster D, So-Armah K, Cheng DM, Blokhina E, Patts G, Lioznov D, Gnatienko N, Long MT, Freiberg MS, Tindle H, Samet JH. Is There an Association Between Cigarette Smoking and Advanced Liver Fibrosis in Smokers with HIV, Heavy Drinking and High Prevalence of HCV? J Clin Med. 2025 Feb 11; 14(4). PMID: 40004700.
Published on 1/27/2025Sun N, Prescott B, Ma J, Xanthakis V, Quatromoni PA, Long MT, Walker ME. The cross-sectional association between ultra-processed food intake and metabolic dysfunction-associated steatotic liver disease. Clin Nutr ESPEN. 2025 Apr; 66:215-220. PMID: 39880205.
Published on 1/1/2025Florea VV, Gajjar P, Huang S, Tang J, Zhao S, Davenport M, Mi MY, Haff M, Zhang X, Miller PE, Vasan RS, Liu CT, Lewis GD, Shah RV, Long MT, Nayor M. Hepatic Steatosis and Fibrosis, Cardiorespiratory Fitness, and Metabolic Mediators in the Community. Liver Int. 2025 Jan; 45(1):e16147. PMID: 39673712.
Published on 11/14/2024Feng G, Targher G, Byrne CD, Yilmaz Y, Wai-Sun Wong V, Adithya Lesmana CR, Adams LA, Boursier J, Papatheodoridis G, El-Kassas M, Méndez-Sánchez N, Sookoian S, Castera L, Chan WK, Ye F, Treeprasertsuk S, Cortez-Pinto H, Yu HH, Kim W, Romero-Gómez M, Nakajima A, Win KM, Kim SU, Holleboom AG, Sebastiani G, Ocama P, Ryan JD, Lup?or-Platon M, Ghazinyan H, Al-Mahtab M, Hamid S, Perera N, Alswat KA, Pan Q, Long MT, Isakov V, Mi M, Arrese M, Sanyal AJ, Sarin SK, Leite NC, Valenti L, Newsome PN, Hagström H, Petta S, Yki-Järvinen H, Schattenberg JM, Castellanos Fernández MI, Leclercq IA, Aghayeva G, Elzouki AN, Tumi A, Sharara AI, Labidi A, Sanai FM, Matar K, Al-Mattooq M, Akroush MW, Benazzouz M, Debzi N, Alkhatry M, Barakat S, Al-Busafi SA, Rwegasha J, Yang W, Adwoa A, Opio CK, Sotoudeheian M, Wong YJ, George J, Zheng MH. Global burden of metabolic dysfunction-associated steatotic liver disease, 2010 to 2021. JHEP Rep. 2025 Mar; 7(3):101271. PMID: 39980749.
Published on 10/16/2024Yiannakou I, Long MT, Jacques PF, Beiser A, Pickering RT, Moore LL. Eggs, Dietary Choline, and Nonalcoholic Fatty Liver Disease in the Framingham Heart Study. J Nutr. 2025 Mar; 155(3):923-935. PMID: 39424072.
Published on 6/14/2024Alanaeme CJ, Ghazi L, Akinyelure OP, Wen Y, Christenson A, Poudel B, Dooley EE, Chen L, Hardy ST, Foti K, Bowling CB, Long MT, Colantonio LD, Muntner P. Trends in the Prevalence of Multiple Chronic Conditions Among US Adults With Hypertension From 1999-2000 Through 2017-2020. Am J Hypertens. 2024 Jun 14; 37(7):493-502. PMID: 38576398.
Published on 6/9/2024Sun N, Prescott B, Ma J, Mohanty A, Long MT, Walker ME. Prevalence of Steatotic Liver Disease Subtypes and Association With Metabolic Risk Factors in the Framingham Heart Study. Clin Gastroenterol Hepatol. 2024 Nov; 22(11):2330-2333. PMID: 38857746.
Media Mentions
Published on 5/5/2025
The habit of drinking certain drinks can cause cirrhosis
Published on 8/4/2023
Is Fatty Liver Disease a Risk Factor for Cardiovascular Disease?
Published on 12/20/2022
Even Non-heavy Drinking May Lead to Liver Problems, Says New Study
Published on 12/20/2022
Even Non-heavy Drinking May Lead to Liver Problems, Says New Study
Published on 12/8/2022
Study finds non-heavy alcohol use associated with liver fibrosis
Published on 8/30/2022
Not the Usual Suspects: Don't Overlook NAFLD in Lean Patients
Published on 7/26/2022
New Update Focuses on NAFLD in Lean People
Published on 7/26/2022
New update focuses on NAFLD in lean people
Published on 6/27/2022
Mixed Bag for Semaglutide in NASH-Related Compensated Cirrhosis
Published on 5/9/2022
Fatigue Tied to Worse Outcomes in Patients With NASH
View full list of 27 media mentions.